1. [Clinicopathological features of metastatic melanoma in effusion cytology of serosal cavity].
- Author
-
Xia Q, Chang XN, Huang B, Li XF, Luo DJ, Wang QJ, Jiang MT, Fan J, and Zhou DW
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Antigens, Neoplasm, Biomarkers, Tumor metabolism, Biomarkers, Tumor genetics, gp100 Melanoma Antigen, High-Throughput Nucleotide Sequencing, Immunohistochemistry, Lung Neoplasms pathology, Lung Neoplasms secondary, Lung Neoplasms metabolism, Lung Neoplasms genetics, MART-1 Antigen metabolism, Melanoma-Specific Antigens metabolism, Mutation, Skin Neoplasms pathology, Skin Neoplasms metabolism, Skin Neoplasms genetics, Melanoma pathology, Melanoma metabolism, Melanoma genetics, Melanoma secondary, Proto-Oncogene Proteins B-raf genetics, S100 Proteins metabolism, SOXE Transcription Factors metabolism, SOXE Transcription Factors genetics
- Abstract
Objective: To investigate the clinical, cytomorphology, immunocytochemical and molecular features of metastatic melanoma in serosal cavity effusion. Methods: Cytological specimens of 14 patients with melanoma in the chest and abdomen were collected from 2017 to 2023, at the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. SOX10, S-100 protein, PRAME, BRAF V600E, HMB45, and Melan A were detected by immunocytochemical methods. Fourteen cases were tested for routine antibody combinations, including Claudin4, HEG1, Calretinin, CD68, etc. Four of the patients had biopsy or surgical samples of metastatic solid lesions of primary sites, and further next-generation sequencing (NGS) or amplification refractory mutation system (ARMS)-PCR molecular test was performed. In addition, 30 cases of serosal effusion samples were collected as control groups (10 cases of benign mesothelial cell reactive hyperplasia, 10 cases of mesothelioma, and 10 cases of metastatic lung adenocarcinoma). Results: Among the 14 cases of melanoma, there were 7 males and 7 females, with ages ranging from 35 to 86 years, and an average age of 57 years, there 10 cases aged ≥50 years. The tumor cells in the serosal effusion varied in morphology and degree of atypia. SOX10 was positive in all 14 cases (14/14), S-100 protein was positive in 10 cases (10/14), PRAME was positive in 12 cases (12/14), BRAF V600E was positive in 10 cases (10/14), HMB45 was positive in 12 cases (12/14), and Melan A was positive in 13 cases (13/14). In 4 patients with histological correlation, the cytological and histological expression of SOX10, BRAF V600E, and PRAME was positive in all 4 cases (4/4); S-100 protein was positive in 2 cases (2/4); and HMB45 and Melan A were positive in 3 cases (3/4). Using NGS or ARMS-PCR, missense mutations of BRAF V600E were detected in all 4 patients; TERT promoter mutations was detected in 1 case; and CDKN2A terminating mutations and MSI1 deletion mutations were detected in the other case. SOX10, S-100, HMB45, Melan A, PRAME and BRAF V600E were all negative in 30 control samples of serosal cavity effusion. Conclusion: By observing the morphology of tumor cells, immunocytochemical test of several combination markers, especially the expression of SOX10, BRAF V600E and PRAME, can help to improve the positive diagnosis rate of melanoma in serous cavity effusion.
- Published
- 2024
- Full Text
- View/download PDF